Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) Guidelines on the Use of Granulocyte Colony-Stimulating Factor (G-CSF) for Lymphoma Care-Reference-Cited by-同舟云学术

Implications of the European Organisation for Research And Treatment Of Cancer (EORTC) Guidelines on the Use of Granulocyte Colony-Stimulating Factor (G-CSF) for Lymphoma Care

Published:2009-08 Issue:8 Volume:29 Page:491-513
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Pettengell Ruth,Aapro Matti,Brusamolino Ercole,Caballero Dolores,Coiffier Bertrand,Pfreundschuh Michael,Trneny Marek,Walewski Jan

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference140 articles.

1. Chemotherapy-induced neutropenia

2. The colony-stimulating factors: use to prevent and treat neutropenia and its complications

3. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

4. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients

5. 2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of pegfilgrastim versus filgrastim for prevention of chemotherapy-induced febrile neutropenia in patients with lymphoma: a systematic review;BMC Health Services Research;2022-12-30

2. Febrile neutropenia risk factors in actively treated diffuse large B-cell lymphoma patients;Iraqi Journal of Hematology;2022

3. Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma;Scientific Reports;2017-06-30

4. Randomized study of granulocyte colony stimulating factor for childhood B-cell non-Hodgkin lymphoma: a report from the Japanese pediatric leukemia/lymphoma study group B-NHL03 study;Leukemia & Lymphoma;2015-12-23

5. Is primary prophylaxis with granulocyte colony stimulating factor (G-CSF) indicated in the treatment of lymphoma?;Transfusion and Apheresis Science;2013-08